Table 1 Baseline sociodemographic, reproductive health, and clinical characteristics according to CHW and CIC groups
From: Recruitment strategies to promote uptake of cervical cancer screening in the West Region of Cameroon
| CIC, n (%) | CHW, n (%) | Total, n (%) | P-value* | |
|---|---|---|---|---|
| Variable | ||||
| Participants recruited | 1356 (69.9%) | 584 (30.1%) | 1940 (100%) | |
| Age (years), mean ± SD | 39.4 (±5.9) | 41.9 (±5.6) | 40.2 (±5.9) | < 0.001 |
| Marital status | < 0.001 | |||
| Single | 121 (8.9%) | 25 (4.3%) | 146 (7.5%) | |
| Married/In a relationship | 1155 (85.2%) | 494 (84.6%) | 1649 (85%) | |
| Divorced/widowed | 78 (5.8%) | 64 (11.0%) | 142 (7.3%) | |
| Education | < 0.001 | |||
| Unschooled | 5 (0.4%) | 9 (1.5%) | 14 (0.7%) | |
| Primary education | 275 (20.3%) | 274 (46.9%) | 549 (28.3%) | |
| Secondary education | 759 (56.0%) | 274 (46.9%) | 1033 (53.3%) | |
| Tertiary education | 315 (23.2%) | 24 (4.1%) | 339 (17.5%) | |
| Employment status | < 0.001 | |||
| Employed | 480 (35.4%) | 62 (10.6%) | 542 (27.9%) | |
| Self-employed | 412 (30.4%) | 121 (20.7%) | 533 (27.5%) | |
| Farmer | 130 (10.0%) | 249 (42.6%) | 379 (19.5%) | |
| Housewife | 274 (20.2%) | 147 (25.2%) | 421 (21.7%) | |
| Student | 50 (3.7%) | 4 (0.7%) | 54 (2.8%) | |
| Unemployed | 8 (0.6%) | 0 | 8 (0.4%) | |
| Age at menarche (years), mean ± SD | 14.6 (1.8) | 14.9 (1.7) | 14.7 (1.8) | < 0.001 |
| Age at first intercourse, mean ± SD | 18.0 (2.9) | 17.48 (2.4) | 17.9 (2.8) | < 0.001 |
| Number of sexual partners, median (IQR) | 3 (2–5) | 3 (2–4) | 3 (2–5) | |
| Age at first delivery (years), mean ± SD | 21.3 (5.8) | 19.8 (4.3) | 20.9 (5.4) | < 0.001 |
| Parity | < 0.001 | |||
| Nulliparous | 65 (4.8%) | 13 (2.2%) | 78 (4.0%) | |
| 1–4 | 662 (48.8%) | 166 (28.4%) | 828 (42.9%) | |
| > 4 | 627 (46.2%) | 404 (69.2%) | 1031 (53.1%) | |
| Tabaco consumption | < 0.001 | |||
| Yes | 7 (0.5%) | 27 (4.6%) | 34 (1.8%) | |
| None | 1347 (99.3%) | 555 (95.0%) | 1902 (98.0%) | |
| Contraception | < 0.001 | |||
| None | 924 (68.1%) | 430 (73.6%) | 1354 (69.8%) | |
| Condom | 189 (13.9%) | 21 (3.6%) | 210 (10.8%) | |
| Hormonal pill | 23 (1.7%) | 8 (1.4%) | 31 (1.6%) | |
| DIU/ implant/ injection | 199 (14.7%) | 117 (20.0%) | 316 (16.3%) | |
| Other | 16 (1.2%) | 5 (0.9%) | 21 (1.1%) | |
| Previous cervical cancer screening | < 0.001 | |||
| None | 1025 (75.6%) | 560 (95.9%) | 1585 (81.7%) | |
| Yes | 329 (24.3%) | 23 (3.9%) | 352 (18.1%) | |
| HIV status (self-reported) | 0.791 | |||
| Negative | 1327 (97.9%) | 574 (98.3%) | 1901 (98.0%) | |
| Positive | 27 (2.0%) | 9 (1.5%) | 36 (1.9%) | |
| HPV testing results | 0.287 | |||
| Negative | 1096 (80.8%) | 484 (82.9%) | 1580 (81.4%) | |
| Positive | 260 (19.2%) | 100 (17.1%) | 360 (18.6%) | |
| HPV-16/18/45 | 59 (4.4%) | 24 (4.1%) | 83 (4.3%) | |
| Other HPV | 215(15.9%) | 86 (14.7%) | 301 (15.5%) | |
| Histology (% of HPV positive women) | 0.437 | |||
| Normal | 179 (68.8%) | 62 (62%) | 241 (66.9%) | |
| CIN1 | 44 (16.9%) | 18 (18%) | 62 (17.2%) | |
| CIN2+ | 28 (10.8%) | 11 (11%) | 39 (10.8%) | |